The Cincinnati Herald: Local panel discusses COVID-19 impact on communities of color
UC Center for Clinical and Translational Science and Training hosts virtual discussion
The Collaboration Network hosted a virtual conference on Racial and Health Inequities Exposed by COVID-19 Thursday, November 19 from 9 a.m. to 11 a.m. Andrew Beck, MD, a Cincinnati Children’s physician and associate professor of pediatrics at the University of Cincinnati, and Karen Bankston, PhD, professor of emerita of the UC College of Nursing, were among those who discussed and presented regional data about COVID-19’s disproportionate impact on communities of color in Greater Cincinnati. The Collaboration Network is a program of the Center for Clinical & Translational Science and Training, run jointly by UC and Cincinnati Children's. The Cincinnati Herald along with other local media covered the virtual discussion.
Read the Cincinnati Herald’s coverage of the virtual meeting.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.